Electroconvulsive therapy as an anticonvulsant. Implications for its mechanism of action in affective illness.
Post
R M
RM
Putnam
F
F
Uhde
T W
TW
Weiss
S R
SR
D000679:Amygdala / Q000187:drug effects; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects; D004049:Diethylcarbamazine / Q000494:pharmacology; D004565:Electroconvulsive Therapy; D005947:Glucose / Q000378:metabolism; D000882:Haplorhini; D007696:Kindling, Neurologic / Q000187:drug effects; D051379:Mice; D009419:Nerve Tissue Proteins / Q000502:physiology; D011963:Receptors, GABA-A / Q000502:physiology; D012640:Seizures / Q000628:therapy; D013004:Somatostatin / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000927:Anticonvulsants; D000928:Antidepressive Agents; D009419:Nerve Tissue Proteins; D011963:Receptors, GABA-A; D013004:Somatostatin; D005680:gamma-Aminobutyric Acid; D005947:Glucose; D004049:Diethylcarbamazine